KRAUSE JAMES 4
4 · NEUROGEN CORP · Filed Dec 23, 2004
Insider Transaction Report
Form 4
NEUROGEN CORPNRGN
KRAUSE JAMES
Senior VP Biology
Transactions
- Award
Stock Option (Right to Buy)
2004-12-21+24,000→ 24,000 totalExercise: $9.05From: 2005-12-21→ Common Stock .025 Par Value Per Share (24,000 underlying)
Footnotes (2)
- [F1]On 12/21/2004 the reporting person was granted an option to purchase 24,000 shares pursuant to the Issuer's Amended and Restated 2001 Neurogen Corporation Stock Option Plan. The options vest in 4 equal annual installments and expire 5 years from each vesting date.
- [F2]Option was granted under an employee stock option plan, for no consideration.